SCHEMBL374658

SCHEMBL374658

c1ccc(Oc2cccc(CNC3CCOCC3)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
KDM4E B2RXH2 3/20 0.53
HTT P42858 2/20 0.53
HPGD P15428 1/20 0.53
PRMT5 O14744 3/20 0.52
WDR77 Q9BQA1 3/20 0.52
SMN1; SMN2 Q16637 1/20 0.47
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
GRIN2B Q13224 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CCR8 P51685 1/20 0.44
MAP4K4 O95819 1/20 0.43
CARM1 Q86X55 1/20 0.43
FFAR1 O14842 3/20 0.43
KDM1A O60341 2/20 0.43
ACHE P22303 1/20 0.43
BACE1 P56817 1/20 0.43
MAOA P21397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8808606 0.86 ALDH1A1 (0.69) ALDH1A1KDM4EHTTPRMT5WDR77
SCHEMBL375093 0.84 ALDH1A1 (0.76) ALDH1A1HTTPRMT5WDR77PDCD1
SCHEMBL7161324 0.83 ALDH1A1 (0.55) ALDH1A1KDM4EHTTPRMT5WDR77
SCHEMBL16117197 0.83 ALDH1A1 (0.55) ALDH1A1KDM4EHTTPRMT5WDR77
SCHEMBL16117204 0.83 ALDH1A1 (0.55) ALDH1A1KDM4EHTTPRMT5WDR77
SCHEMBL375264 0.82 GRIN2B (0.62) GRIN2BMEN1KMT2ACARM1ACHE
SCHEMBL375222 0.81 CARM1 (0.61) ALDH1A1PRMT5WDR77MAP4K4CARM1
SCHEMBL374999 0.81 ALDH1A1 (0.52) ALDH1A1PRMT5WDR77PDCD1CD274
SCHEMBL17308302 0.77 ALDH1A1 (0.49) ALDH1A1PRMT5WDR77PDCD1CD274
SCHEMBL382597 0.77 MAP4K4 (0.46) ALDH1A1PRMT5WDR77PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623898-B2 Glycine transporter inhibiting substances TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-01-07 US disclosed
EP-2409976-A1 GLYCINE TRANSPORTER INHIBITOR Taisho Pharmaceutical Co., Ltd. (JP) 2012-01-25 EP disclosed
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES SLC18A2, SLC1A2, SLC6A1 ALDH1A1 1730/4885KDM4E 4384/4885HTT 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.